Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
- 1 June 2001
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (6) , 459-468
- https://doi.org/10.1038/sj.cgt.7700326
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 25 references indexed in Scilit:
- A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1Cancer Gene Therapy, 2000
- Antisense raf Oligodeoxyribonucleotide Is a Radiosensitizer In VivoAntisense and Nucleic Acid Drug Development, 1999
- An Overview of Progress in Antisense TherapeuticsAntisense and Nucleic Acid Drug Development, 1998
- Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancerGene Therapy, 1997
- Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- The design and development of DaunoXome® for solid tumor targeting in vivoAdvanced Drug Delivery Reviews, 1997
- Antitumor Effect of c-myc Antisense Phosphorothioate Oligodeoxynucleotides on Human Melanoma Cells In Vitro and in MiceJNCI Journal of the National Cancer Institute, 1996
- Efficacy of Gentamicin or Ceftazidime Entrapped in Liposomes with Prolonged Blood Circulation and Enhanced Localization in Klebsiella pneumoniae-Infected Lung TissueThe Journal of Infectious Diseases, 1995
- Encapsulation of Vincristine in Liposomes Reduces its Toxicity and Improves its Anti-Tumor EfficacyJournal of Liposome Research, 1995
- Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumorCancer Letters, 1990